EA
STJ

Emerald Acquisition’s St Jude Medical STJ Stock Holding History

Emerald Acquisition’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$35.1M Sell
440,013
-1,176,428
-73% -$95M 0.07% 349
2016
Q2 		$126M Buy
+1,616,441
New +$115M 0.22% 99

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Emerald Acquisition's STJ Position: Q3 2016 in Review

Emerald Acquisition reduced its St Jude Medical (STJ) stake by 73% in Q3 2016, selling an estimated $95M and leaving 440,013 shares worth $35.1M. The position accounts for 0.07% of the portfolio, ranked #349.

Emerald Acquisition first reported a position in STJ in Q2 2016 and has held it in 2 quarters since. The position peaked at $126M in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Emerald Acquisition held 440,013 shares of St Jude Medical worth $35.1M as of Q3 2016.
  • Emerald Acquisition sold 1,176,428 St Jude Medical shares in Q3 2016, an estimated $95M.
  • St Jude Medical made up 0.07% of Emerald Acquisition's portfolio in Q3 2016, its #349 holding.
  • Emerald Acquisition first reported a position in St Jude Medical in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's St Jude Medical position peaked at $126M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.